Tumor T(1) Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model

PURPOSE: To assess whether T(1) relaxation time of tumors may be used to assess response to bevacizumab anti-angiogenic therapy. Procedures: 12 female nude mice bearing subcutaneous SKOV3ip1-LC ovarian tumors were administered bevacizumab (6.25ug/g, n=6) or PBS (control, n=6) therapy twice a week fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravoori, Murali K., Nishimura, Masato, Singh, Sheela P., Lu, Chunhua, Han, Lin, Hobbs, Brian P., Pradeep, Sunila, Choi, Hyun J., Bankson, James A., Sood, Anil K., Kundra, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476738/
https://www.ncbi.nlm.nih.gov/pubmed/26098849
http://dx.doi.org/10.1371/journal.pone.0131095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476738/
https://www.ncbi.nlm.nih.gov/pubmed/26098849
http://dx.doi.org/10.1371/journal.pone.0131095

Ejemplares similares